L-carnosine for Schizophrenia

NACompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

March 31, 2004

Primary Completion Date

November 30, 2007

Study Completion Date

December 31, 2007

Conditions
SchizophreniaSchizoaffective Disorder
Interventions
DRUG

L-carnosine (dietary supplement)

an antioxidant and AGE inhibitor, 500 mg/day, titration each week to reach 2000 mg/day in 4 weeks L-Carnosine is a dietary supplement

Trial Locations (4)

15132

Mon-Yough Community Services, Inc., McKeesport

15213

Western Psychiatric Institute and Clinic, Pittsburgh

15801

Dubois Regional Medical Center, DuBois

15107-1599

Mayview State Hospital, Bridgeville

All Listed Sponsors
collaborator

Stanley Medical Research Institute

OTHER

lead

University of Pittsburgh

OTHER

NCT00177177 - L-carnosine for Schizophrenia | Biotech Hunter | Biotech Hunter